Medicament formulation containing dihydropyridines and a process

Details Medicament formulation containing dihydropyridines and a process Medicament formulation containing dihydropyridines and a process

1986-04-16

1990-12-11

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

264 41, 264 43, 264 46, 4284022, 424417, A61K 3722, A61K 2526, B32B 516, B01J 1302

Patent

active

049769642

ABSTRACT:
In the parenteral administration of a dihydropyridine, the improvement which comprises administering the dihydropyridine in an aqueous medium of pH 3 to 8.5 having dispersed therein liposomes with an average diameter of 20-1000 nm, the liposome membrane containng the following constituents by weight:

REFERENCES:
Chemical Abstracts, Band 91, 1979, Columbus, Ohio, USA, Y. Matsuno et al., "Lolubilizotion of nifedipine" Seite 350, Spalte 1, Zusammenfassung-Nr. 163 057s & Jpn. Kokai Tokkyo Koho, 79-55 714, Ota Pharmaceutical Co. Ltd.; Tokai Capsule Co., Ltd.
Chemical Abstracts 102: 2255k (1-7-85).

Affiliated with

Also associated with

Rating

Medicament formulation containing dihydropyridines and a process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament formulation containing dihydropyridines and a process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament formulation containing dihydropyridines and a process will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-389053